skip to main content
Idioma:
Mostrar Somente
Refinado por: Nome da Publicação: European Journal Of Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Power doppler with use of contrast in the differentiation of ovarian tumors
Power doppler with use of contrast in the differentiation of ovarian tumors
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Power doppler with use of contrast in the differentiation of ovarian tumors

E. C. Blanco J. P Carvalho; Ângela Maggio da Fonseca; J. A Pinotti; A. R Pastore; Roberto Hegg; A. J Salomão; The European Cancar Conference (11. 2001 Lisboa)

European Journal of Cancer Reino Unido v. 37, supl. 6, p. S322, poster 1195, 2003

Reino Unido 2001

Item não circula. Consulte sua biblioteca.(Acessar)

2
Probability and estimation of malignancy in women with pelvic masses, using a logistic model which combines age, morphological ultrasound pattern and resistence index determination
Probability and estimation of malignancy in women with pelvic masses, using a logistic model which combines age, morphological ultrasound pattern and resistence index determination
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Probability and estimation of malignancy in women with pelvic masses, using a logistic model which combines age, morphological ultrasound pattern and resistence index determination

E. C. Blanco Ângela Maggio da Fonseca; J. P Carvalho; J. A Pinotti; A. R Pastore; Roberto Hegg; A. J Salomão; The European Cancar Conference (11. 2001 Lisboa)

European Journal of Cancer Reino Unido v. 37, supl. 6, p. S340, poster 1266, 2003

Reino Unido 2001

Item não circula. Consulte sua biblioteca.(Acessar)

3
Phase ii trial of navelbine (nvb) in advanced breast cancer (abc)
Phase ii trial of navelbine (nvb) in advanced breast cancer (abc)
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Phase ii trial of navelbine (nvb) in advanced breast cancer (abc)

E Mickiewicz O Fernandez; S Bruno; C Delgado; L Teixeira; L Martinez; V Lira Puerto; C Nogueira; A Solidoro; J Otero; Roberto Hegg; F M Delgado; European Conference on Clinical Oncology and Cancer Nursing (6. 1991 Firenze)

v.27, n.2 supl., p.s66, 1991 European Journal of Cancer

1991

Item não circula. Consulte sua biblioteca.(Acessar)

4
Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study
Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study

B Chevallier C Brown; P F Bruning; L Deschenes; Roberto Hegg; A Malzyner; N Marschner; A Paterson; K I Prichard; D Serin; M Spielmann; European Conference on Clinical Oncology and Cancer Nursing (6. 1991 Firenze)

v.27, n.2 supl., p.s55, 1991 European Journal of Cancer

1991

Item não circula. Consulte sua biblioteca.(Acessar)

5
Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2
Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

Sonke, G.S ; Hart, L.L ; Campone, M ; Erdkamp, F ; Janni, W ; Verma, S ; Villanueva, C ; Jakobsen, E ; Alba, E ; Wist, E ; Favret, A.M ; Bachelot, T ; Hegg, R ; Wheatley-Price, P ; Souami, F ; Sutradhar, S ; Miller, M ; Germa, C ; Burris, H.A

European journal of cancer (1990), 2017-02, Vol.72, p.S1-S2 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
1945 Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival according to body weight and anti-drug antibody status
1945 Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival according to body weight and anti-drug antibody status
Material Type:
Artigo 		Adicionar ao Meu Espaço

1945 Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival according to body weight and anti-drug antibody status

Jackisch, C ; Hegg, R ; Stroyakovskiy, D ; Ahn, J.S ; Melichar, B ; Chen, S.C ; Crepelle-Fléchais, A ; Lauer, S ; Shing, M ; Pivot, X

European journal of cancer (1990), 2015-09, Vol.51, p.S313-S314 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)
2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)

Oza, A.M ; Selle, F ; Davidenko, I ; Korach, J ; Mendiola, C ; Gocze, P ; Pautier, P ; Chmielowska, E ; Bamias, A ; DeCensi, A ; Zvirbule, Z ; Gonzalez-Martin, A ; Hegg, R ; Joly, F ; Zamagni, C ; Gadducci, A ; Deurloo, R ; Revil, C ; Robb, S ; Colombo, N

European journal of cancer (1990), 2015-09, Vol.51, p.S532-S532 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
192 Pertuzumab and Trastuzumab in Combination with an Anthracycline-containing or an Anthracycline-free Standard Chemotherapy in the Neoadjuvant Treatment of HER2-positive Breast Cancer (TRYPHAENA)
192 Pertuzumab and Trastuzumab in Combination with an Anthracycline-containing or an Anthracycline-free Standard Chemotherapy in the Neoadjuvant Treatment of HER2-positive Breast Cancer (TRYPHAENA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

192 Pertuzumab and Trastuzumab in Combination with an Anthracycline-containing or an Anthracycline-free Standard Chemotherapy in the Neoadjuvant Treatment of HER2-positive Breast Cancer (TRYPHAENA)

Schneeweiss, A ; Chia, S ; Hickish, T ; Harvey, V ; Hegg, R ; Tausch, C ; Seo, J.H ; Tsai, Y.F ; McNally, V ; Cortes, J

European journal of cancer (1990), 2012-03, Vol.48, p.S96-S96 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
3506 POSTER Clinical Characteristics and Outcome of Treatment of Brazilian Women With Breast Cancer Treated at Public and Private Institutions
3506 POSTER Clinical Characteristics and Outcome of Treatment of Brazilian Women With Breast Cancer Treated at Public and Private Institutions
Material Type:
Artigo 		Adicionar ao Meu Espaço

3506 POSTER Clinical Characteristics and Outcome of Treatment of Brazilian Women With Breast Cancer Treated at Public and Private Institutions

Hegg, R ; Mattar, A ; Emereciano, K ; Pinotti, M ; Perdicaris, M ; van Eyll, B ; Franke, F ; Pinczowski, H ; Freitas, R ; Jendiroba, D

European journal of cancer (1990), 2011, Vol.47, p.S248-S248 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
351 (PB-146) - NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer
351 (PB-146) - NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

351 (PB-146) - NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer

Ruiz Borrego, M. ; Hegg, R. ; Staroslawska, E. ; Morales, S. ; Cinieri, S. ; De Freitas Junior, R. ; Garcia Estevez, L. ; Szombara, E. ; Hervieu, H. ; Groc, M. ; Villanova, G. ; Aapro, M.

European journal of cancer (1990), 2018-04, Vol.92, p.S98-S98 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (14)
  2. Revistas revisadas por pares (14)

Data de Publicação 

De até
Refinar
  1. Antes de1995  (3)
  2. 1995Até1996  (1)
  3. 1997Até2000  (3)
  4. 2001Até2011  (5)
  5. Após 2011  (7)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.